Substance-Related Disorders
326
19
28
259
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Published Results
53 trials with published results (16%)
Research Maturity
259 completed trials (79% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.5%
8 terminated out of 326 trials
97.0%
+10.5% vs benchmark
14%
47 trials in Phase 3/4
20%
53 of 259 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 259 completed trials
Clinical Trials (326)
SMART-r: Substance Monitoring and Active Relapse Tracking Repository
Research on Outpatient Adolescent Treatment for Comorbid Substance Use and Internalizing Disorders
Feasibility of the 5-Step Method in the U.S.
Pathway-Matched Resilience-Oriented Therapy in Rwanda
Disrupting SRFOH to Improve Substance Use and Mental Health Outcomes for Parents in Rural Regions
Whole Health in VA Mental Health: Omnis Salutis
CMAP Plus Intervention for Self-harm in Individuals With Substance Use Disorder in Pakistan
Maternal Brain Imaging in Opioid Use Disorder
Cross-sectional Functional Stratification Based on Psychometric Profiling and Machine Learning in Patients With Substance Use Disorders (SUD)
Evaluation of the Efficacy of the Individually Adjusted Therapy Scale (ATI) on the Addiction Severity
Prevention of Relapse in Behavioral Disorders
Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder
Evaluating an Adverse Childhood Experience-Targeting Advocate Model of a Substance Use Prevention Program
CRP and S&A for Inpatient Veterans
Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)
Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention
We The Village Family Support Study
Developing and Evaluating a Machine-Learning Opioid Overdose Prediction & Risk-Stratification Tool in Primary Care
Preventing Impaired Driving Among Adolescents
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention